Copyright © 1995 by the European Society of Cardiology.
©1995 The European Society of Cardiology
Clinical validation of a quality of life questionnaire in angina pectoris patients

*Mapi, Lyon France
Synthelabo, Meudon La Foret France
accepted 22 February 1995.
Correspondence: Patrick Marquis, MAPI, 27 rue de la Villette, 69003 Lyon, France.
Abstract
Angina pectoris impairs patients' quality of life. In order to assess its impact on quality of life, a questionnaire was developed using a literature review and interviews with patients and clinicians. It consisted of a general profile (SF-36) which measured functional status, well-being, perceived health, and a specific index, the Angina Pectoris Quality of Life Questionnaire, supplemented by new items. The acceptability, internal consistency reliability and clinical validity of this 70-item questionnaire were analysed in a cross-sectional study. Of 197 coronary patients approached, 93% (n=184) agreed to participate and 86% (n=170) returned the mailed questionnaire. Mean age of patients was 67 years (±10); 79% were male and 70% were retired. Sixty patients were asymptomatic and 110 reported anginal crises (Canadian Cardiovascular Society Classification: class I: 48; II: 37; III: 13; IV: 0; V: 12). Globally, angina pectoris was found to affect each quality of life concept measured: physical functioning, well-being, and perceived health. Quality of life profiles worsened in accordance with increasing severity of the condition, as stratified by angina pectoris class. Asymptomatic patients reported better general and specific profiles. These results support the feasibility and usefulness of evaluating quality of life using the questionnaire. The validation of the data is very encouraging and enables the questionnaire to be used in clinical trials.
Key Words: Angina pectoris quality of life SF-36 angina pectoris quality of life questionnaire validation
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M A Buser, P T Buser, G M Kuster, L Grize, M Pfisterer, and for the TIME Investigators Improvements in physical and mental domains of quality of life by anti-ischaemic drug and revascularisation treatment in elderly men and women with chronic angina Heart, November 1, 2008; 94(11): 1413 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S Sansgiry, C. Chien, S. S Jayawant, and A. Raju Comparison of the Short-Form Survey 12 and the MacNew Heart Disease Health-Related Quality of Life Survey Among Patients with Cardiac Disease Ann. Pharmacother., February 1, 2008; 42(2): 200 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Hofkamp, C. A. Henrikson, and S. T. Wegener An Interactive Model of Pain and Myocardial Ischemia Psychosom Med, September 1, 2007; 69(7): 632 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Forleo, C. Tondo, L. De Luca, A. D. Russo, M. Casella, V. De Sanctis, F. Clementi, R. L. Fagundes, R. Leo, F. Romeo, et al. Gender-related differences in catheter ablation of atrial fibrillation Europace, August 1, 2007; 9(8): 613 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Schroter and D L Lamping Coronary revascularisation outcome questionnaire (CROQ): development and validation of a new, patient based measure of outcome in coronary bypass surgery and angioplasty Heart, December 1, 2004; 90(12): 1460 - 1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Chen, N. F. Marrouche, Y. Khaykin, A. M. Gillinov, O. Wazni, D. O. Martin, A. Rossillo, A. Verma, J. Cummings, D. Erciyes, et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1004 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Olson, S. F. Kelsey, K. Matthews, L. J. Shaw, B. L. Sharaf, G. M. Pohost, C. E. Cornell, S. P. McGorray, D. Vido, and C.N. Bairey Merz Symptoms, myocardial ischaemia and quality of life in women:: Results from the NHLBI-sponsored WISE Study Eur. Heart J., August 2, 2003; 24(16): 1506 - 1514. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ekre, T. Eliasson, H. Norrsell, P. Wahrborg, and C. Mannheimer Long-term effects of spinal cord stimulation and coronary artery bypass grafting on quality of life and survival in the ESBY study Eur. Heart J., December 2, 2002; 23(24): 1938 - 1945. [Abstract] [PDF] |
||||
![]() |
M.P van den Berg, R.J Hassink, A.E Tuinenburg, E.F.L.P van Sonderen, J.D Lefrandt, P.J de Kam, I.C van Gelder, A.J Smit, R Sanderman, and H.J.G.M Crijns Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system Eur. Heart J., February 1, 2001; 22(3): 247 - 253. [Abstract] [PDF] |
||||
![]() |
R. Jansen, M. G. Niemeyer, T. J. Cleophas, and A. H. Zwinderman Factors Influencing Efficacy of Nitrate Therapy for Stable Angina Pectoris: A Multiple Linear Regression Analysis Angiology, December 1, 2000; 51(12): 1007 - 1012. [Abstract] [PDF] |
||||
![]() |
A. H. Zwinderman, T. J. Cleophas, H. van der Sluijs, M. G. Niemeyer, B. P. Buunk, E. E. van der Wall, T. J. Cleophas, and Dutch Mononitrate Quality of Life Study Group Comparison of 50-mg and 100-mg Sustained-Release Isosorbide Mononitrate in the Treatment of Stable Angina Pectoris: Effects on Quality-of-Life Indices Angiology, December 1, 1999; 50(12): 963 - 969. [Abstract] [PDF] |
||||
![]() |
M. G. Niemeyer, H. A. J. Kleinjans, R. de Ree, A. H. Zwinderman, T. J. M. Cleophas, E. E. van der Wall, A.J.M. Cleophas, and Dutch Mononitrate Quality of Life Study Group Comparison of Multiple-Dose and Once-Daily Nitrate Therapy in 1212 Patients with Stable Angina Pectoris: Effects on Quality of Life Indices Angiology, October 1, 1997; 48(10): 855 - 862. [Abstract] [PDF] |
||||






